FDA should consider drug-therapy regimens
Year of publication
2024
Authors
Castrén, Eero; Normann, Claus
Organizations and authors
University of Helsinki
Castrén Eero
Publication type
Publication format
Article
Parent publication type
Journal
Article type
Other article
Audience
ScientificPeer-reviewed
Non Peer-ReviewedMINEDU's publication type classification code
B1 Non-refereed journal articlesPublication channel information
Open access
Open access in the publisher’s service
No
Open access of publication channel
Partially open publication channel
Self-archived
No
Other information
Fields of science
Neurology and psychiatry
Publication country
United States
Internationality of the publisher
International
Language
English
International co-publication
Yes
Co-publication with a company
No
DOI
10.1126/science.adt1480
The publication is included in the Ministry of Education and Culture’s Publication data collection
Yes